Podcast

Podcast
High Symptom Burden Among Patients With Advanced Upper GI Cancer Undergoing Chemotherapy
February 19, 2021
Xin Shelley Wang, MD, MPH, discusses results from a real-world study exploring PROs of symptom burden and functioning among patients with advanced esophageal, gastroesophageal…
Podcast
High Symptom Burden Among Patients With Advanced Upper GI Cancer Undergoing Chemotherapy
February 19, 2021
Xin Shelley Wang, MD, MPH, discusses results from a real-world study exploring PROs of symptom burden and functioning…
Podcast
NCCN Guideline Adherence Improves Survival Outcomes in Anal Cancer
February 04, 2021
Priyanka Kumar, MD, discusses a recent study which analyzed adherence to the NCCN treatment guidelines for anal…
Podcast
High Economic Burden of HCC Treated With Loco-Regional Therapies
January 27, 2021
Brian Seal, PhD, RPh, MBA discusses results from a study which examined the lines of loco-regional therapies received…
Podcast
Real-World Practice Patterns and Predictors of Survival in Older Patients With MCL
January 15, 2021
David Bond, MD, discusses real-world clinical outcomes and predictors of survival in older patients with MCL treated in…
Podcast
Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy
January 14, 2021
Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later…
Podcast
First-Line Ibrutinib Effective for CLL/SLL Irrespective of Cytogenetic or Mutational Risk Features
December 10, 2020
Jan Burger, MD, PhD, discusses an analysis of the RESONATE-2 and iLLUMINATE studies, which explored outcomes of first-…
Engaging Experts
Real-World Outcomes of First-Line Ibrutinib vs Chemoimmunotherapy for CLL
December 06, 2020
Lori Leslie, MD, discusses results from a real-world study evaluating clinical outcomes in high-risk and non-high-risk…
Podcast
Treatment Options for Patients With Relapsed/Refractory FL
October 15, 2020
Elizabeth Brem, MD, discusses data from studies exploring the best treatment approaches for patients with relapsed/…
Engaging Experts
Economic Burden of CML Treatment in the US: Before and After the Availability of Generic Imatinib
October 03, 2020
Gary Lyman, MD, Fred Hutchinson Cancer Research Center, discusses a project exploring the cost of TKIs, particularly…
Podcast
Assessing Response to Follicular Lymphoma Treatment
September 24, 2020
Peter Martin, MD, discusses the prognostic value of PET/CT status after long-term follow-up for recipients of first-…